Intranasal corticosteroids in pediatric airway inflammation: From pharmacokinetics and evidence to optimized clinical practice.
Intranasal corticosteroids (INS) are widely recommended as first-line therapy for pediatric upper airway disorders due to their potent local anti-inflammatory effects and favorable safety profile. This narrative review evaluates current evidence regarding the pharmacologic properties, clinical efficacy, and safety of I...